中国血液净化 ›› 2025, Vol. 24 ›› Issue (07): 586-589.doi: 10.3969/j.issn.1671-4091.2025.07.009

• 综述 • 上一篇    下一篇

基于多组学鉴定动静脉内瘘功能障碍机制的研究进展

黎  欣     覃新芳   

  1. 541001 桂林,1桂林医学院附属医院肾脏内科
  • 收稿日期:2024-10-31 修回日期:2025-02-26 出版日期:2025-07-12 发布日期:2025-07-12
  • 通讯作者: 覃新芳 E-mail:772145607@qq.com

Research progress in the identification of arteriovenous fistula dysfunction mechanism based on multiomics

LI Xin, QIN Xin-fang   

  1. Department of Nephrology, The Affiliated Hospital of Guilin Medical University, Guilin 541001, China
  • Received:2024-10-31 Revised:2025-02-26 Online:2025-07-12 Published:2025-07-12
  • Contact: 541001 桂林,1桂林医学院附属医院肾脏内科 E-mail:772145607@qq.com

摘要: 动静脉内瘘(arteriovenous fistula,AVF)与其他通路方式相比有着感染率和并发症发生率较低的优点,是目前透析患者首选的血管通路方式,但其成熟率和功能障碍的问题一直是临床关注的焦点。AVF功能障碍的早期诊断通常依赖于先进的影像学技术,目前针对这一问题的临床有效诊断、治疗、和预后评估的方法很少,且对于导致AVF功能障碍的分子生物学研究也并不透彻。近年来,随着科学技术的发展基因组学、转录组学、蛋白组学、代谢组学等技术在揭示AVF功能障碍疾病特征和辅助疾病诊断方面发挥着重要作用,因此本文基于多组学对可能导致AVF功能障碍的分子生物学机制进行梳理与总结。

关键词: 动静脉内瘘功能障碍, 多组学, 研究进展

Abstract: Arteriovenous fistula (AVF) has the advantages of lower infection and complication rates than other access methods, and is currently the preferable vascular access method for hemodialysis patients. However, delayed maturity rate and dysfunction of AVF are frequently concerned by clinicians. Early diagnosis of dysfunctional AVF usually depends on the advanced imaging techniques, and methods in terms of effective clinical diagnosis, treatment, and prognostic evaluation are virtually rare. The mechanistic role of molecular biology in the pathogenesis of AVF dysfunction is incompletely understood. Currently, the development of genomics, transcriptomics, proteomics, and metabolomics technologies have played great roles in insight into the pathological features and clinical diagnosis of AVF dysfunction. This article summarizes and reviews the molecular biology mechanisms underlying the AVF dysfunction based on multiomics.

Key words: Arteriovenous fistula dysfunction, Multiomics, Research progress

中图分类号: